EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML
- Study Type:
- EXPANDED_ACCESS
- Last Updated:
- 2017-08-22
Conditions
- Secondary AML
Interventions
- DRUG
No Results Yet